Condition
Breast Cancer
Breast cancer is a disease in which breast cells grow out of control, often fueled by hormones such as estrogen. Among supplements, vitamin D has drawn the most attention, and in one small trial of women starting aromatase-inhibitor treatment, joint pain improved. That study included only 60 women, so the evidence is limited and needs larger trials to confirm it.
Sources: PMID 19655244
- Supplements studied
- 15
- Medicines and peptides
- 2
- Graded outcomes
- 24
- Trials
- 18
- People studied
- 13,466
Evidence by supplement
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anxiety Symptoms Large Improvement | Improves (the measure goes down) | Large effect | 128 people | |||
| Depression Symptoms Large Improvement | Improves (the measure goes down) | Large effect | 304 people | |||
| Stress Signs and Symptoms | Improves (the measure goes down) | 1 study | 177 people | |||
Studies that measured stress signs and symptoms | ||||||
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Menopausal Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 12 studies | 135 people | ||
Studies that measured menopausal symptoms
| ||||||
| Breast Density No effect | NoneNo effect | 1 study | 65 people | |||
Calendula Officinalis
- Dermatitis Risk: improves
- Itching: improves
- Pain: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Dermatitis Risk Small Improvement | Improves (the measure goes down) | Small effect | 3 studies | 756 people | ||
Studies that measured dermatitis risk
| ||||||
| Itching | Improves (the measure goes up) | 420 people | ||||
| Pain | Changes; see studies | 420 people | ||||
Vitamin D
- Aromatase-Inhibitor Related Joint Pain: improves
- Breast Cancer Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Aromatase-Inhibitor Related Joint Pain Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 60 people | ||
Studies that measured aromatase-inhibitor related joint pain | ||||||
| Breast Cancer Risk | Changes; see studies | 2 studies | 3,861 people | |||
Studies that measured breast cancer risk | ||||||
Reishi
- Anxiety Symptoms: improves
- Depression Symptoms: improves
- Fatigue Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anxiety Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 48 people | ||
Studies that measured anxiety symptoms | ||||||
| Depression Symptoms | Improves (the measure goes down) | 48 people | ||||
| Fatigue Symptoms | Improves (the measure goes down) | 48 people | ||||
| Subjective Well-Being | Improves (the measure goes up) | 48 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 48 people | ||||
Turkey tail mushroom
- Lymphocyte Count: improves
- Natural Killer Cell Activity
- Natural Killer Cell Content: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Lymphocyte Count Moderate Increase | Improves (the measure goes up) | Moderate effect | 9 people | |||
| Natural Killer Cell Activity No effect | NoneNo effect | 1 study | 9 people | |||
Studies that measured natural killer cell activity | ||||||
| Natural Killer Cell Content | Improves (the measure goes up) | 9 people | ||||
DIM
- SHBG Levels: improves
- Tamoxifen Metabolism: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| SHBG Levels Increased SHBG suggesting favorable hormone environment | Improves (the measure goes up) | Moderate effect | 130 people | |||
| Tamoxifen Metabolism CONCERNING: Reduced endoxifen and tamoxifen metabolites - may reduce efficacy | Improves (the measure goes down) | Moderate effect | 130 people |
Sulforaphane
- Cell Proliferation Markers: improves
- HDAC Activity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cell Proliferation Markers Reduced Ki-67 expression and cell proliferation in early-stage | Improves (the measure goes down) | Moderate effect | 60 people | |||
| HDAC Activity Decreased histone deacetylase activity | Improves (the measure goes down) | Moderate effect | 40 people |
Calcium-D-Glucarate
- Cancer Prevention (Preclinical): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cancer Prevention (Preclinical) In rodent models, dietary calcium D-glucarate (typically 4% of diet, equivalent to very high human doses) reduced tumor incidence across multiple cancer types including mammary, lung, skin, liver, and colon tumors induced by chemical carcinogens such as DMBA, benzo[a]pyrene, and diethylnitrosamine. No human clinical trials have been conducted. | Improves (the measure goes down) | Moderate effect | 8 studies | |||
Naringenin
- Breast Cancer Cell Proliferation: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Breast Cancer Cell Proliferation Naringenin and other citrus flavonoids inhibited human breast cancer cell proliferation in vitro, with IC50 values of 5.9-140 microg/mL. Combined flavonoids showed synergistic effects. In rats, citrus juice delayed mammary tumorigenesis after carcinogen exposure (PMID 8875554). A separate review noted anti-mammary cancer potential of citrus flavonoids (PMID 9781306). All evidence is preclinical. | Changes; see studies | Small effect | 3 studies | |||
Grape Seed Extract
- Estrogen
- Testosterone: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Estrogen No effect | NoneNo effect | 1 study | 46 people | |||
Studies that measured estrogen | ||||||
| Testosterone | Improves (the measure goes up) | 46 people | ||||
Melatonin
- Breast Cancer Risk
- IGF-1: improves
- Estrogen: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Breast Cancer Risk No effect | NoneNo effect | 1 study | 863 people | |||
Studies that measured breast cancer risk | ||||||
| IGF-1 | Improves (the measure goes up) | 1 study | 86 people | |||
Studies that measured igf-1 | ||||||
| Estrogen | Changes; see studies | 86 people | ||||
Red Clover Extract
- Breast Density
- Menopausal Symptoms: improves
- Hot Flash Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Breast Density No effect | NoneNo effect | 177 people | ||||
| Menopausal Symptoms | Improves (the measure goes down) | 5 studies | 177 people | |||
| Hot Flash Symptoms | Improves (the measure goes down) | 1 study | 177 people | |||
| Estrogen | Changes; see studies | 177 people | ||||
| Follicle-Stimulating Hormone | Improves (the measure goes up) | 177 people | ||||
| Luteinizing Hormone | Improves (the measure goes up) | 177 people |
Saffron
- Depression Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Depression Symptoms | Improves (the measure goes down) | 18 studies | 62 people |
Resveratrol
- DNA methylation: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| DNA methylation | Changes; see studies | 1 study | 39 people |
Prescription medicines and peptides studied, for context
Goserelin (Zoladex)
- Disease Control (Breast): improves
- Ovarian Function Suppression: improves
- Estrogen Suppression: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Disease Control (Breast) Effective for HR-positive breast cancer. Monthly and 3-monthly formulations show equivalent efficacy. | Improves (the measure goes up) | Moderate effect | 18 studies | |||
| Ovarian Function Suppression Preferred option for OFS in premenopausal breast cancer. Established safety profile in clinical trials. | Improves (the measure goes down) | Large effect | 8 studies | |||
| Estrogen Suppression Achieves effective estrogen suppression in premenopausal women for hormone receptor-positive breast cancer. | Improves (the measure goes down) | Large effect | 7 studies |
Triptorelin (Trelstar)
- Disease-Free Survival (Breast): improves
- Ovarian Function Suppression: improves
- Ovarian Preservation: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Disease-Free Survival (Breast) SOFT/TEXT trials showed OFS plus tamoxifen provides significant DFS benefit in premenopausal patients. HOBOE trial validated efficacy. | Improves (the measure goes up) | Moderate effect | 17 studies | |||
| Ovarian Function Suppression Used in TEXT and SOFT trials for premenopausal breast cancer. Approved in EU and US for adjuvant treatment with tamoxifen or AI. | Improves (the measure goes down) | Large effect | 11 studies | |||
| Ovarian Preservation GIM/PROMISE-GIM6 study: reduces chemotherapy-induced early menopause. Enables fertility preservation in young breast cancer patients. | Improves (the measure goes up) | Moderate effect | 11 studies |
Key findings
- Anxiety SymptomsImproves (the measure goes down)
- Depression SymptomsImproves (the measure goes down)
- Menopausal SymptomsImproves (the measure goes down)
The Breast Cancer (Supportive Care) protocol
2 primary supplements · 2 supporting supplements
- Vitamin D2,000–4,000 IU daily (titrate to 40–60 ng/mL)
- Turkey Tail Mushroom (PSK)3 g daily
Studies cited
4 studies from PubMed
- Effects of CBT-based interventions on health outcomes in breast cancer patients: a systematic review and Meta-analysis.
- The effects of mindfulness-based stress reduction on psychosocial outcomes and quality of life in early-stage breast cancer patients: a randomized trial
- Which specific modes of exercise training are most effective for breast related cancer fatigue? Network meta-analysis.
- The Effect of Ketogenic Diet on Weight Loss in Adult Patients with Cancer: A Systematic Review and Meta-Analysis of Controlled Clinical Trials